ResearcherUniversity of AlbertaActive in the last 2 years
Vera Christine Mazurak
Matched on ORCID iD 0000-0002-7724-6354; OpenAlex author ID A5085437923. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic canc… Last author DOI 10.1002/ncp.70096↗
- Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancre… First author DOI 10.1016/j.clnu.2024.06.037↗
- Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic Cancer. Last author DOI 10.3390/cancers15174368↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Vickie Elaine Baracos · 3 shared papers, 2023–2026 · strength 0.79
- Paper Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during c… DOI 10.1002/ncp.70096↗
- Paper Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanc… DOI 10.1016/j.clnu.2024.06.037↗
- Paper Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic … DOI 10.3390/cancers15174368↗
- Pamela N. Klassen · 3 shared papers, 2023–2026 · strength 0.79
- Paper Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during c… DOI 10.1002/ncp.70096↗
- Paper Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanc… DOI 10.1016/j.clnu.2024.06.037↗
- Paper Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic … DOI 10.3390/cancers15174368↗
- Michael B. Sawyer · 3 shared papers, 2023–2026 · strength 0.79
- Paper Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during c… DOI 10.1002/ncp.70096↗
- Paper Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanc… DOI 10.1016/j.clnu.2024.06.037↗
- Paper Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic … DOI 10.3390/cancers15174368↗
- Christina Kim · 1 shared paper, 2026 · strength 0.33
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.